Site-specific Methylation of the Rat Prolactin and Growth Hormone Promoters Correlates with Gene Expression

Overview

Journal Mol Cell Biol

Specialty Cell Biology

Date 1996 Jul 1

PMID 8668139

Citations 14

Authors

V Ngo

D Gourdji

J N Laverriere

Affiliations

Soon will be listed here.

Abstract

The methylation patterns of the rat prolactin (rPRL) (positions -440 to -20) and growth hormone (rGH) (positions -360 to -110) promoters were analyzed by bisulfite genomic sequencing. Two normal tissues, the anterior pituitary and the liver, and three rat pituitary GH3 cell lines that differ considerably in their abilities to express both genes were tested. High levels of rPRL gene expression were correlated with hypomethylation of the CpG dinucleotides located at positions -277 and -97, near or within positive cis-acting regulatory elements. For the nine CpG sites analyzed in the rGH promoter, an overall hypomethylation-expression coupling was also observed for the anterior pituitary, the liver, and two of the cell lines. The effect of DNA methylation was tested by measuring the transient expression of the chloramphenicol acetyltransferase reporter gene driven by a regionally methylated rPRL promoter. CpG methylation resulted in a decrease in the activity of the rPRL promoter which was proportional to the number of modified CpG sites. The extent of the inhibition was also found to be dependent on the position of methylated sites. Taken together, these data suggest that site-specific methylation may modulate the action of transcription factors that dictate the tissue-specific expression of the rPRL and rGH genes in vivo.

Citing Articles

Exploring the influence of DNA methylation and single nucleotide polymorphisms of the gene on growth traits in the hybrid grouper ( (female) × (male)).

Cao L, Ma J, Chen P, Hou X, Yang N, Lu Y Front Genet. 2024; 14:1277647.

PMID: 38259615 PMC: 10801740. DOI: 10.3389/fgene.2023.1277647.

Unveiling the gene regulatory landscape in diseases through the identification of DNase I-hypersensitive sites.

Chen Y, Chen A Biomed Rep. 2019; 11(3):87-97.

PMID: 31423302 PMC: 6684942. DOI: 10.3892/br.2019.1233.

Manipulation of the Growth Hormone-Insulin-Like Growth Factor (GH-IGF) Axis: A Treatment Strategy to Reverse the Effects of Early Life Developmental Programming.

Reynolds C, Perry J, Vickers M Int J Mol Sci. 2017; 18(8).

PMID: 28786951 PMC: 5578119. DOI: 10.3390/ijms18081729.

Cell Type-Specific Sexual Dimorphism in Rat Pituitary Gene Expression During Maturation.

Bjelobaba I, Janjic M, Kucka M, Stojilkovic S Biol Reprod. 2015; 93(1):21.

PMID: 26063874 PMC: 4706308. DOI: 10.1095/biolreprod.115.129320.

Epigenetic characterization of the growth hormone gene identifies SmcHD1 as a regulator of autosomal gene clusters.

Massah S, Hollebakken R, Labrecque M, Kolybaba A, Beischlag T, Prefontaine G PLoS One. 2014; 9(5):e97535.

PMID: 24818964 PMC: 4018343. DOI: 10.1371/journal.pone.0097535.

References

Clark S, Harrison J, Paul C, Frommer M . High sensitivity mapping of methylated cytosines. Nucleic Acids Res. 1994; 22(15):2990-7. PMC: 310266. DOI: 10.1093/nar/22.15.2990. View

Brandeis M, Frank D, Keshet I, Siegfried Z, Mendelsohn M, Nemes A . Sp1 elements protect a CpG island from de novo methylation. Nature. 1994; 371(6496):435-8. DOI: 10.1038/371435a0. View

Roy R, Vallieres L, Leclerc S, Guerin S . The rat growth hormone proximal silencer contains a novel DNA-binding site for multiple nuclear proteins that represses basal promoter activity. Eur J Biochem. 1994; 225(1):419-32. DOI: 10.1111/j.1432-1033.1994.00419.x. View

Cherington P, TASHJIAN Jr A . Clonal analysis of a 5-azacytidine-induced specific increase in growth hormone production by rat pituitary cells. Endocrinology. 1983; 113(1):418-20. DOI: 10.1210/endo-113-1-418. View

Ivarie R, Schacter B, Ofarrell P . The level of expression of the rat growth hormone gene in liver tumor cells is at least eight orders of magnitude less than that in anterior pituitary cells. Mol Cell Biol. 1983; 3(8):1460-7. PMC: 369992. DOI: 10.1128/mcb.3.8.1460-1467.1983. View

Laverriere J, Muller M, Buisson N, Tougard C, Tixier-Vidal A, Martial J . Differential implication of deoxyribonucleic acid methylation in rat prolactin and rat growth hormone gene expressions: a comparison between rat pituitary cell strains. Endocrinology. 1986; 118(1):198-206. DOI: 10.1210/endo-118-1-198. View

Saluz H, Jiricny J, Jost J . Genomic sequencing reveals a positive correlation between the kinetics of strand-specific DNA demethylation of the overlapping estradiol/glucocorticoid-receptor binding sites and the rate of avian vitellogenin mRNA synthesis. Proc Natl Acad Sci U S A. 1986; 83(19):7167-71. PMC: 386676. DOI: 10.1073/pnas.83.19.7167. View

Larsen P, Harney J, Moore D . Repression mediates cell-type-specific expression of the rat growth hormone gene. Proc Natl Acad Sci U S A. 1986; 83(21):8283-7. PMC: 386912. DOI: 10.1073/pnas.83.21.8283. View

Gutierrez-Hartmann A, Siddiqui S, Loukin S . Selective transcription and DNase I protection of the rat prolactin gene by GH3 pituitary cell-free extracts. Proc Natl Acad Sci U S A. 1987; 84(15):5211-5. PMC: 298824. DOI: 10.1073/pnas.84.15.5211. View

10.

Glass C, Franco R, Weinberger C, Albert V, Evans R, Rosenfeld M . A c-erb-A binding site in rat growth hormone gene mediates trans-activation by thyroid hormone. Nature. 1987; 329(6141):738-41. DOI: 10.1038/329738a0. View

11.

Nelson C, Albert V, Elsholtz H, Lu L, Rosenfeld M . Activation of cell-specific expression of rat growth hormone and prolactin genes by a common transcription factor. Science. 1988; 239(4846):1400-5. DOI: 10.1126/science.2831625. View

12.

Bodner M, Castrillo J, Theill L, Deerinck T, Ellisman M, Karin M . The pituitary-specific transcription factor GHF-1 is a homeobox-containing protein. Cell. 1988; 55(3):505-18. DOI: 10.1016/0092-8674(88)90037-2. View

13.

Toth M, Lichtenberg U, DOERFLER W . Genomic sequencing reveals a 5-methylcytosine-free domain in active promoters and the spreading of preimposed methylation patterns. Proc Natl Acad Sci U S A. 1989; 86(10):3728-32. PMC: 287213. DOI: 10.1073/pnas.86.10.3728. View

14.

Borrelli E, HEYMAN R, Arias C, Sawchenko P, Evans R . Transgenic mice with inducible dwarfism. Nature. 1989; 339(6225):538-41. DOI: 10.1038/339538a0. View

15.

Mangalam H, Albert V, Ingraham H, Kapiloff M, Wilson L, Nelson C . A pituitary POU domain protein, Pit-1, activates both growth hormone and prolactin promoters transcriptionally. Genes Dev. 1989; 3(7):946-58. DOI: 10.1101/gad.3.7.946. View

16.

Zhang Z, Kumar V, Rivera R, Pasion S, Chisholm J, Biswas D . Suppression of prolactin gene expression in GH cells correlates with site-specific DNA methylation. DNA. 1989; 8(8):605-13. DOI: 10.1089/dna.1989.8.605. View

17.

Laverriere J, Richard J, Buisson N, Martial J, Tixier-Vidal A, Gourdji D . Thyroliberin and dihydropyridines modulate prolactin gene expression through interacting pathways in GH3 cells. Neuroendocrinology. 1989; 50(6):693-701. DOI: 10.1159/000125301. View

18.

Elsholtz H, Albert V, Treacy M, Rosenfeld M . A two-base change in a POU factor-binding site switches pituitary-specific to lymphoid-specific gene expression. Genes Dev. 1990; 4(1):43-51. DOI: 10.1101/gad.4.1.43. View

19.

Pan W, Liu Q, Bancroft C . Identification of a growth hormone gene promoter repressor element and its cognate double- and single-stranded DNA-binding proteins. J Biol Chem. 1990; 265(12):7022-8. View

20.

SIMMONS D, Voss J, Ingraham H, Holloway J, Broide R, Rosenfeld M . Pituitary cell phenotypes involve cell-specific Pit-1 mRNA translation and synergistic interactions with other classes of transcription factors. Genes Dev. 1990; 4(5):695-711. DOI: 10.1101/gad.4.5.695. View